Stock Information
BridgeBio Pharma Inc (BBIO)
Ticker Symbol: BBIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $14,096.65 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.7841
Revenue (TTM): $2.59 M
Dividend Yield: N/A%
ROE: -206.74%
Latest News
-
BridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4: 30 pm ET
Thu, Apr 30, 2026 7:30 AM
-
BridgeBio: Attruby's Early Dominance Makes The Bull Case Hard To Ignore
Wed, Apr 29, 2026 5:58 PM
-
Truist Securities Maintains Buy on BridgeBio Pharma, Raises Price Target to $102
Wed, Apr 29, 2026 9:19 AM
-
HC Wainwright & Co. Reiterates Buy on BridgeBio Pharma, Maintains $100 Price Target
Wed, Apr 29, 2026 8:02 AM
-
Mizuho Reiterates Outperform on BridgeBio Pharma, Maintains $106 Price Target
Tue, Apr 28, 2026 10:39 AM
-
BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White
Tue, Apr 28, 2026 7:30 AM
-
BridgeBio Pharma shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $100 price target.
Mon, Apr 27, 2026 11:43 AM
Key Financials
Financial data not available
